Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Pfizer paying up to $725 million for Alzheimer drug rights
Marketwatch
Wednesday, September 3, 2008 - 8:52am
tags:
Novartis: Tekturna better than diuretic for obese patients
Marketwatch
Wednesday, September 3, 2008 - 8:48am
tags:
Vytorin Study's Ethical Morass
Forbes
Wednesday, September 3, 2008 - 8:47am
tags:
Has Lilly's Effient Been FDA Approved?
Seeking Alpha
Wednesday, September 3, 2008 - 8:46am
tags:
Teva sells Ivax Diagnostics stake
Globes Online, Israel
Wednesday, September 3, 2008 - 8:43am
tags:
Zentiva CEO tells shareholders to reject Sanofi bid
Reuters
Wednesday, September 3, 2008 - 8:43am
tags:
Neurocrine Biosciences Announces Successful Elagolix PETAL Study in Endometriosis
Marketwatch
Wednesday, September 3, 2008 - 8:40am
tags:
Docs' caution over possible cholesterol drug-cancer link hurts Merck, Schering-Plough shares
Yahoo/AP
Tuesday, September 2, 2008 - 6:46pm
tags:
Shares of drug developer AtheroGenics fall after bond payment default
Yahoo/AP
Tuesday, September 2, 2008 - 6:45pm
tags:
King pays Pain Therapeutics $20 million
Yahoo/AP
Tuesday, September 2, 2008 - 6:44pm
tags:
Youth Suicides Rose After Stiffer Warnings Curbed Antidepressant Use
WSJ Online
Tuesday, September 2, 2008 - 6:40pm
tags:
Lipitor Is Back on the Tube
Motley Fool
Tuesday, September 2, 2008 - 6:39pm
tags:
Two Drug Companies For Easy-Mode Investors (BMY, LLY)
Investopedia
Tuesday, September 2, 2008 - 6:38pm
tags:
Drug maker Eli Lilly says long-acting version of Zyprexa shows low relapse rate
Yahoo/AP
Tuesday, September 2, 2008 - 6:38pm
tags:
Cardiologists Hate Vytorin
Motley Fool
Tuesday, September 2, 2008 - 6:37pm
tags:
Big Pharma Pipeline: Why So Dry?
Seeking Alpha
Tuesday, September 2, 2008 - 6:37pm
tags:
Fresenius buyout of APP Pharmaceuticals expected to clear by mid-September
Yahoo/AP
Tuesday, September 2, 2008 - 6:36pm
tags:
No Vindication For Vytorin; Victory for Sciele
CNBC
Tuesday, September 2, 2008 - 6:35pm
tags:
Eli Lilly says experimental blood thinner beat Plavix at stopping heart attacks in diabetics
Yahoo/AP
Tuesday, September 2, 2008 - 6:35pm
tags:
Japanese Drug Industry Makes Another Billion-Dollar U.S. Buy
WSJ Online
Tuesday, September 2, 2008 - 6:34pm
tags:

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.